Matt Panuwat has been appointed chief business officer at ORIC Pharmaceuticals, a clinical-stage oncology company focused developing novel therapies against treatment-resistant cancers. Mr. Panuwat will serve on the executive leadership team and will lead business and corporate development.    Mr. Panuwat previously served as senior vice president of business development at Prothena, where he led partnership activities and established the company’s global R&D collaboration with Celge...